You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSIs

Showing 1 - 25 of 222
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Sclerosis Trial in Vienna (EDSS, Discussion of symptoms, Patient reported outcome (MSIS))

Completed
  • Multiple Sclerosis
  • EDSS
  • Discussion of symptoms, Patient reported outcome (MSIS)
  • Vienna, Austria
    Medical University of Vienna
Jan 19, 2022

Is EBJIS Definition of Prosthetic Joint Infection Meaningful in

Recruiting
  • Periprosthetic Joint Infection (PJI)
  • data collection to classify infection status
  • Porto, Portugal
  • +1 more
Nov 10, 2021

Shotgun Metagenomics in Diagnosis of Complex Prosthetic Joint

Not yet recruiting
  • Prosthetic Joint Infection
    • Brest, France
      Brest university hospital
    Sep 25, 2023

    Prosthetic Joint Infection Trial in Bordeaux (68Ga-citrate PET/CT)

    Recruiting
    • Prosthetic Joint Infection
    • 68Ga-citrate PET/CT
    • Bordeaux, France
      CHU de Bordeaux - service de maladies infectieuses
    Jan 20, 2023

    MS Patients Treated With Sphingosine-1-phosphate Receptor

    Recruiting
    • Multiple Sclerosis
    • S1PR analysis on immune cells
    • Bern, Switzerland
      Neurology department
    Apr 12, 2023

    Ofatumumab in Portuguese Multiple Sclerosis Patients

    Not yet recruiting
    • Relapsing Multiple Sclerosis
    • Ofatumumab
    • (no location specified)
    Mar 30, 2023

    WOE of Anti-CD20 Therapies

    Not yet recruiting
    • Multiple Sclerosis
    • (no location specified)
    Oct 31, 2023

    Multiple Sclerosis, Epilepsy, Parkinson Disease Trial in Pozzilli (Psychometric Evaluations)

    Enrolling by invitation
    • Multiple Sclerosis
    • +4 more
    • Psychometric Evaluations
    • Pozzilli, Isernia, Italy
      Ircss Neuromed
    Dec 19, 2022

    Multiple Sclerosis, Insomnia Trial in Uppsala (i-CBT, Applied relaxation)

    Not yet recruiting
    • Multiple Sclerosis
    • Insomnia
    • i-CBT
    • Applied relaxation
    • Uppsala, Uppland, Sweden
      Department of Psychology, Uppsala University
    Sep 1, 2023

    Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Training groupe, PNF,

    Completed
    • Multiple Sclerosis, Chronic Progressive
    • Multiple Sclerosis, Primary Progressive
    • Training groupe
    • +3 more
    • Kaposvár, Somogy, Hungary
      Somogy Megyei Kaposi Mór Oktató Kórház
    Mar 24, 2022

    Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Demyelinating Autoimmune Diseases, CNS Trial in Amsterdam

    Recruiting
    • Multiple Sclerosis
    • +5 more
    • Amsterdam, Netherlands
      Amsterdam UMC, location VUmc
    Apr 17, 2023

    Relapsing Remitting Multiple Sclerosis Trial in Portland (3 mg Melatonin, 5 mg Melatonin)

    Active, not recruiting
    • Relapsing Remitting Multiple Sclerosis
    • 3 mg Melatonin
    • 5 mg Melatonin
    • Portland, Oregon
      Providence MS Center
    May 5, 2022

    Kesimpta® in Swiss Multiple Sclerosis Patients -Observational

    Recruiting
    • Multiple Sclerosis
    • Ofatumumab
    • Baden, Aargau, Switzerland
    • +17 more
    Jan 20, 2023

    Transitioning Patients From Natalizumab to Ocrelizumab

    Completed
    • Relapsing Remitting Multiple Sclerosis
      • Livingston, New Jersey
      • +4 more
      Feb 2, 2022

      Multiple Sclerosis Trial in Saint Petersburg (Fludarabine Phosphate for Injection)

      Recruiting
      • Multiple Sclerosis
      • Fludarabine Phosphate for Injection
      • Saint Petersburg, Russian Federation
        First Pavlov State Medical University of St. Petersburg
      Apr 14, 2023

      Multiple Sclerosis Trial in Bordeaux (DigiCog (BCCAMS app), Konectom Application)

      Completed
      • Multiple Sclerosis
      • DigiCog (BCCAMS app)
      • Konectom Application
      • Bordeaux, France
        Research Site
      Sep 21, 2022

      Infection Consortium Study#1

      Not yet recruiting
      • PJI
      • Synovasure® Comprehensive Infection Panel
      • (no location specified)
      Nov 22, 2023

      Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Chronic Progressive Trial in Cleveland (Cionic

      Recruiting
      • Multiple Sclerosis
      • +2 more
      • Cionic Neural Sleeve NS-100
      • Actigraph accelerometer
      • Cleveland, Ohio
        Cleveland State University
      Jul 25, 2023

      Multiple Sclerosis Trial in Littleton (Neubie)

      Completed
      • Multiple Sclerosis
      • Neubie
      • Littleton, Colorado
        Centura Health at Home
      Aug 10, 2022

      Kesimpta® Treatment Effects in Relapsing Multiple Sclerosis

      Recruiting
      • Multiple Sclerosis
      • Ofatumumab
      • Bamberg, Bavaria, Germany
      • +21 more
      Jan 25, 2023

      Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary-progressive Multiple Sclerosis Trial in Belgium (Metformin

      Not yet recruiting
      • Multiple Sclerosis
      • +2 more
      • Metformin Hydrochloride 850 mg Oral Tablet
      • Placebo
      • Brugge, Belgium
      • +4 more
      May 30, 2023

      Pediatric Onset Multiple Sclerosis (POMS) Trial in Houston (VR active video game intervention, Educational session, Standard

      Terminated
      Has Results
      • Pediatric Onset Multiple Sclerosis (POMS)
      • VR active video game intervention
      • +2 more
      • Houston, Texas
        The University of Texas Health Science Center,Houston
      May 17, 2022

      Multiple Sclerosis Trial (Frexalimab, Placebo, MRI contrast-enhancing agents)

      Not yet recruiting
      • Multiple Sclerosis
      • (no location specified)
      Nov 15, 2023

      Multiple Sclerosis Trial in Worldwide (MSCopilot® mobile application)

      Not yet recruiting
      • Multiple Sclerosis
      • MSCopilot® mobile application
      • Oklahoma City, Oklahoma
      • +6 more
      Apr 3, 2023

      Metastatic Breast Cancer Trial in Philadelphia (Adapted Intimacy Enhancement, Intimacy Facts and Resources)

      Recruiting
      • Metastatic Breast Cancer
      • Adapted Intimacy Enhancement
      • Intimacy Facts and Resources
      • Philadelphia, Pennsylvania
        Fox Chase Cancer Center
      Dec 5, 2022